Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004984155 | SCV005613638 | uncertain significance | Inborn genetic diseases | 2024-10-12 | criteria provided, single submitter | clinical testing | The c.13925C>G (p.A4642G) alteration is located in exon 53 (coding exon 53) of the KMT2C gene. This alteration results from a C to G substitution at nucleotide position 13925, causing the alanine (A) at amino acid position 4642 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |